Bibliographic record

Mechanisms of action and therapeutic application of glucagon-like peptide-1

Drucker DJ. Cell Metabolism 2018

Document identifier: CEI-BR-016
Series: Bibliographic record
Version: 1.0
Published: 30 Jul 2026
Last reviewed: 30 Jul 2026
Certainty: Not rated

§1Bibliographic record

§1.1Record

Authors: Drucker DJ
Title: Mechanisms of action and therapeutic application of glucagon-like peptide-1
Source: Cell Metabolism
Year: 2018
Volume, issue, pages: 27(4):740–756
Digital object identifier: 10.1016/j.cmet.2018.03.001
PubMed identifier: 29617641
Record type: Journal article
Institute identifier: CEI-BR-016

§1.2Institute documents citing this record

Table 1. Documents in the Institute set that cite this record.

Document	Series
Monograph: Semaglutide	Compound monograph
Monograph: Liraglutide	Compound monograph
Monograph: Dulaglutide	Compound monograph
Monograph: Exenatide	Compound monograph
Monograph: Lixisenatide	Compound monograph
Monograph: Orforglipron	Compound monograph
Monograph: Danuglipron	Compound monograph
Monograph: Ecnoglutide	Compound monograph
Monograph: Teduglutide	Compound monograph
Synthesis: Dulaglutide in type 2 diabetes mellitus: effect on the anchor outcome	Evidence synthesis
Synthesis: Exenatide in type 2 diabetes mellitus: effect on the anchor outcome	Evidence synthesis
Synthesis: Lixisenatide in type 2 diabetes mellitus: effect on the anchor outcome	Evidence synthesis
Synthesis: Orforglipron in type 2 diabetes mellitus: effect on the anchor outcome	Evidence synthesis
Synthesis: Exenatide in atherosclerotic cardiovascular disease and…	Evidence synthesis
Synthesis: Liraglutide in obesity and overweight in adults: effect on the anchor…	Evidence synthesis
Synthesis: Orforglipron in obesity and overweight in adults: effect on the…	Evidence synthesis
Synthesis: Teduglutide in inflammatory bowel disease and mucosal barrier…	Evidence synthesis
Synthesis: Dulaglutide in atherosclerotic cardiovascular disease and…	Evidence synthesis
Synthesis: Liraglutide in adjunctive therapy in type 1 diabetes: effect on the…	Evidence synthesis
Synthesis: Liraglutide in type 2 diabetes mellitus: effect on the anchor outcome	Evidence synthesis
Synthesis: Dulaglutide in type 2 diabetes mellitus: tolerability and…	Evidence synthesis
Synthesis: Exenatide in type 2 diabetes mellitus: tolerability and…	Evidence synthesis
Synthesis: Lixisenatide in type 2 diabetes mellitus: tolerability and…	Evidence synthesis
Synthesis: Orforglipron in type 2 diabetes mellitus: tolerability and…	Evidence synthesis
Synthesis: Exenatide in atherosclerotic cardiovascular disease and…	Evidence synthesis
Synthesis: Liraglutide in obesity and overweight in adults: tolerability and…	Evidence synthesis
Synthesis: Orforglipron in obesity and overweight in adults: tolerability and…	Evidence synthesis
Synthesis: Teduglutide in inflammatory bowel disease and mucosal barrier…	Evidence synthesis
Synthesis: Dulaglutide in atherosclerotic cardiovascular disease and…	Evidence synthesis
Synthesis: Liraglutide in adjunctive therapy in type 1 diabetes: tolerability…	Evidence synthesis
Synthesis: Liraglutide in type 2 diabetes mellitus: tolerability and…	Evidence synthesis
Synthesis: Dulaglutide in type 2 diabetes mellitus: durability of effect	Evidence synthesis
Synthesis: Exenatide in type 2 diabetes mellitus: durability of effect	Evidence synthesis
Synthesis: Lixisenatide in type 2 diabetes mellitus: durability of effect	Evidence synthesis
Synthesis: Orforglipron in type 2 diabetes mellitus: durability of effect	Evidence synthesis
Synthesis: Exenatide in atherosclerotic cardiovascular disease and…	Evidence synthesis
Synthesis: Liraglutide in obesity and overweight in adults: durability of effect	Evidence synthesis
Synthesis: Orforglipron in obesity and overweight in adults: durability of effect	Evidence synthesis
Synthesis: Teduglutide in inflammatory bowel disease and mucosal barrier…	Evidence synthesis
39 citing documents.

§1.3Subject tags

glp-1 mechanism review

Compound Evidence Institute · CEI-BR-016 · https://compoundevidence.com/bibliography/drucker2018/ · retrieved 30 July 2026